New estimates from a study published in The Lancet Oncology forecast that by 2050, the annual incidence of breast cancer could rise to over 3.5 million new cases. This projection underscores the growing impact of the disease on a global scale, notably highlighting Greece's situation where breast cancer incidence remains relatively high. Despite these alarming figures, improvements have been noted, with Greece achieving a roughly 20% reduction in mortality rates from breast cancer since 1990.

Breast cancer continues to be a leading cause of premature death among women worldwide. In 2023 alone, approximately 2.3 million new cases were documented, with a staggering 73% of these cases arising in high-income and upper-middle-income countries. There were also about 764,000 reported deaths related to the disease, with notable percentages of victims from low-income regions, illustrating the disparities in healthcare access and outcomes linked to economic status.

Researchers analyzed cancer registry data covering the years from 1990 to 2023, drawing information from a wide array of 204 countries and regions. They conducted interviews with family members and caregivers of women who have succumbed to breast cancer, aiming to deepen the understanding around the disease's incidence, treatment, and the ongoing need for support systems in both high and low-income countries. This comprehensive approach may guide future healthcare policies and initiatives aimed at combating breast cancer effectively.